PREVALENSI DAN PROFIL KOMORBIDITAS PADA PASIEN DIABETES MELLITUS PROGRAM RUJUK BALIK KLINIK PRATAMA MAKMUR JAYA, TANGERANG SELATAN TAHUN 2025
DOI:
https://doi.org/10.31004/prepotif.v10i1.56730Keywords:
Diabetes Mellitus, Komorbid, Pasien Rujuk Balik, Fasilitas Kesehatan Tingkat PertamaAbstract
Diabetes mellitus (DM) merupakan salah satu penyakit tidak menular yang menjadi masalah kesehatan global dengan prevalensi kasus yang terus meningkat setiap tahun. Di Indonesia, DM merupakan salah satu penyakit kronis dengan prevalensi tinggi yang banyak ditemukan di fasilitas pelayanan kesehatan tingkat pertama (FKTP). Namun demikian, data mengenai prevalensi dan pola komorbiditas pada pasien DM di FKTP masih terbatas. Penelitian ini bertujuan untuk menghitung prevalensi dan profil komorbiditas pada pasien DM peserta program pasien rujuk balik (PRB) di Klinik Pratama Makmur Jaya, Tangerang Selatan, tahun 2025. Penelitian deskriptif desain retrospektif dilakukan berdasarkan data rekam medis pasien PRB-DM. Terdapat 104 pasien DM (n=104) di Klinik Pratama Makmur Jaya yang sebagian besar berada pada kelompok usia >60 tahun (n=72; 69,2%), diikuti oleh kelompok usia 45–59 tahun (n=26; 25,0%) dan <45 tahun (n=6; 5,8%). Berdasarkan jenis kelamin, pasien lebih banyak perempuan (n=57; 52,9%) dibandingkan dengan laki-laki (n=47; 47,1%). Komorbiditas yang paling sering ditemukan adalah hipertensi (n=28; 26,9%), diikuti penyakit jantung (n=25; 24,0%) dan stroke (n=13; 12,5%), sedangkan komorbiditas respirasi seperti penyakit paru obstruktif kronik/PPOK (n=5; 4,8%) dan asma (n=1; 1,0%) ditemukan dalam proporsi yang lebih kecil. Secara keseluruhan, hasil ini menunjukkan bahwa komorbiditas kardiovaskular merupakan komorbiditas yang paling dominan pada pasien DM dalam penelitian ini.References
De Santi, F., Zoppini, G., Locatelli, F., Finocchio, E., Cappa, V., Dauriz, M., & Verlato, G. (2017). Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population. BMC Pulmonary Medicine, 17(1), 101.https://doi.org/10.1186/s12890-017-0443-1
Debora, J. A. (2024). Hubungan hipertensi, diabetes melitus tipe 2, penyakit jantung, dan kadar high density lipoprotein (HDL) dengan kejadian stroke iskemik berulang di RSUD Dr. H. Abdul Moeloek. Skripsi. Fakultas Kedokteran, Universitas Lampung. Tersedia pada: https://digilib.unila.ac.id/79184/
Hamza, L. N., & Jallab, H. R. (2024). Risk Factors That Lead To Poor Glycemic Control In Type 2 Diabetic Patients Attending Al Diwaniya Diabetes Mellitus Center In 2023. Obat: Jurnal Riset Ilmu Farmasi Dan Kesehatan, 2(5), 248–270. https://doi.org/10.61132/obat.v2i5.679
Huang, L., Zeng, J., Luo, Y., Wang, H., Zhang, Z., & Zeng, Y. (2025). The comorbidity burden of diabetes and stroke: a retrospective study in Beijing, China. BMC Public Health, 25(1), 546. https://doi.org/10.1186/s12889-025-21705-8
International Diabetes Federation. (2026). IDF Diabetes Atlas 2025. Diakses 1 Maret 2026, dari https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/
Kobylianskiĭ, V. I., Babadzhanova, Gi., & Suntsov, I. (2010). [Association between chronic obstructive pulmonary diseases and diabetes mellitus, type I and II]. Terapevticheskii arkhiv, 82(3), 13–18. http://europepmc.org/abstract/MED/20564914
Mosenzon, O., Cheng, A. Y., Rabinstein, A. A., & Sacco, S. (2023). Diabetes and Stroke: What Are the Connections? Journal of Stroke, 25(1), 26–38. https://doi.org/10.5853/jos.2022.02306
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., Lindstedt, P. A., Aali, A., Abate, Y. H., Abate, M. D., Abbasian, M., Abbasi-Kangevari, Z., Abbasi-Kangevari, M., Abd ElHafeez, S., Abd-Rabu, R., … Vos, T. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
Papanas, N., Tsimihodimos, V., Katsiki, N., Doupis, J., Pagkalos, E., Nikas, N., Papakonstantopoulos, N., Karpouzos, G., & Tentolouris, N. (2025). Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study). Journal of Diabetes and Its Complications, 39(8), 109087. https://doi.org/10.1016/j.jdiacomp.2025.109087
Regina, S & Atzmardina, Z. (2024). Kunjungan kasus diabetes mellitus, hipertensi, dan hiperkolesteolemia pada ny. wn dengan pendekatan kedokteran keluarga. 8, 3277–3282. https://doi.org/10.31004/prepotif.v8i2.25484
Shuvo, S. Das, Hossen, M. T., Riazuddin, M., Hossain, M. S., Mazumdar, S., Parvin, R., & Elahi, M. T. (2023). Prevalence of comorbidities and its associated factors among type-2 diabetes patients: a hospital-based study in Jashore District, Bangladesh. BMJ Open, 13(9), e076261. https://doi.org/10.1136/bmjopen-2023-076261
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., & Mbanya, J. C. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
Yin, H.-L., Yin, S.-Q., Lin, Q.-Y., Xu, Y., Xu, H.-W., & Liu, T. (2017). Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis. Medicine, 96(19), e6836. https://doi.org/10.1097/MD.0000000000006836
Zhang, Y.-L., Wu, B.-J., Chen, P., & Wen, H.-H. (2022). The prevalence, awareness, management and influencing factors of diabetes in middle-aged and elderly in China, evidence from the CHARLS in 2015. Medicine, 101(50). https://doi.org/10.1097/MD.0000000000032348
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ayat Rahayu, Komalasari Komalasari, Fajr Muzzammil, Sakinah Mawaddah Ramadhaniah, Nurul Fathia Shafira Amiyanti, Abdul Rahman
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
